SCHOTT Pharma AG & Co KgaA

SCHOTT Pharma AG & Co's GHG Emissions Data Preview

In 2023, SCHOTT Pharma AG & Co completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy), and Scope 3 (indirect emissions across the value chain).

However, SCHOTT Pharma AG & Co has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)	2024	2023	2022	2021 - 2017
Total Scope 1 Total direct GHG emissions from categories that are owned or directly controlled by the company.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 2 Indirect GHG emissions from the generation of purchased electricity, steam, heating, and cooling consumed by the reporting company.
Market-Based Indirect emissions from purchased energy calculated using the market-based method, which reflects contractual instruments such as supplier-specific emission factors or renewable energy certificates (RECs).	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Location-Based Indirect emissions from purchased energy calculated using the location-based method, which reflects average emission factors of the local grid.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000
Total Scope 3 All other indirect GHG emissions that occur in the company’s value chain, outside of Scope 1 and 2. This includes both upstream and downstream activities.	Data available for purchase 0000000	Copy restricted. Please purchase to unlock this data.	Copy restricted. Please purchase to unlock this data.	Data available for purchase 0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into SCHOTT Pharma AG & Co's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of SCHOTT Pharma AG & Co amounted to 73,813 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Insights into SCHOTT Pharma AG & Co's Value Chain Emissions

In 2023, SCHOTT Pharma AG & Co reported 532 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.

The 2023 disclosure of SCHOTT Pharma AG & Co includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in , demonstrating consistent Scope 3 emissions reporting coverage year over year.

Insights into SCHOTT Pharma AG & Co's Total Carbon Footprint

In 2023, SCHOTT Pharma AG & Co reported a total carbon footprint of 74,345 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions.

The largest contributor to SCHOTT Pharma AG & Co's total carbon footprint was Scope 2 emissions, accounting for 58.63% of the company's total carbon footprint, followed by Scope 1 emissions at 40.66%.